<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02551302</url>
  </required_header>
  <id_info>
    <org_study_id>Ortho-6-2015</org_study_id>
    <nct_id>NCT02551302</nct_id>
  </id_info>
  <brief_title>&quot;Efficacy of Hybrid Systems (&quot;Topping Off&quot;) Versus Rigid Spinal Fusion in Lumbar Fusion Surgery: A Dual-center, Prospective, Randomized Pilot Study (&quot;CD Horizon BalanC&quot;)&quot;</brief_title>
  <acronym>BalanC</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cologne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Cologne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Effectiveness of hybrid systems (&quot;topping off&quot;) compared to rigid spondylodesis in fusion&#xD;
      surgery of the lumbar spine: A prospective, randomized, bicentric pilot study (&quot;CD HORIZON&#xD;
      BalanC™)&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Posterior spondylodesis and monosegmental intervertebral cage plus flexible spondylodesis of&#xD;
      the superiorly adjacent segment (CD HORIZON BalanC™ Manufacturer: Medtronic)&#xD;
&#xD;
      Control:&#xD;
&#xD;
      Posterior spondylodesis and monosegmental intervertebral cage&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>October 2015</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in the subscores of physical pain and physical function in the ODI Questionaire</measure>
    <time_frame>Baseline to 6 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>MCS and individual dimensions and subscales of the SF-36™</measure>
    <time_frame>60 Month</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Spine Surgery</condition>
  <arm_group>
    <arm_group_label>PLIF</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The control group will receive a monosegmental posterior lumbar spine fusion with an intervertebral cage (PLIF).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hybrid system (PLIF + flexible pedicle screw system above the</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The intervention group will receive a hybrid system with a PLIF and a flexible pedicle screw system above the fusion.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Solera™ Medtronic</intervention_name>
    <description>The control group will receive a monosegmental posterior lumbar spine fusion with an intervertebral cage (PLIF). Solera™ Medtronic</description>
    <arm_group_label>PLIF</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CD HORIZON BalanC™ Medtronic</intervention_name>
    <description>The intervention group will receive a hybrid system with a PLIF and a flexible pedicle screw system above the fusion. Surgery will be performed with the following devices:&#xD;
CD HORIZON BalanC™ Medtronic</description>
    <arm_group_label>Hybrid system (PLIF + flexible pedicle screw system above the</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Informed consent&#xD;
&#xD;
          -  Legal capacity&#xD;
&#xD;
          -  Age ≥ 30 years&#xD;
&#xD;
          -  Indication for monosegmental lumbar spine fusion (PLIF or &quot;topping-off &quot;) L2-S1 with&#xD;
             osteochondrosis Modic grades I-III [20][21][22] or spondylolisthesis Meyerding grades&#xD;
             I-III.&#xD;
&#xD;
          -  Radiologic signs of degeneration in the adjacent segment of the intended fusion&#xD;
             without signs of instability&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Motor deficit&#xD;
&#xD;
          -  Cauda equina syndrome&#xD;
&#xD;
          -  Previous surgical intervention of the lumbar spine&#xD;
&#xD;
          -  Relevant peripheral neuropathy&#xD;
&#xD;
          -  Acute denervation subsequent to a radiculopathy&#xD;
&#xD;
          -  Scoliosis with Cobb angle greater than 25°&#xD;
&#xD;
          -  Spondylolisthesis &gt; Meyerding grade III&#xD;
&#xD;
          -  Radiologic signs of degeneration in the adjacent segment of the intended fusion with&#xD;
             signs of instability (for definition, see inclusion criteria)&#xD;
&#xD;
          -  No radiologic signs of degeneration in the adjacent segment of the intended fusion&#xD;
             (for definition, see inclusion criteria)&#xD;
&#xD;
          -  Radiologic signs of degeneration in the adjacent segment of the intended fusion with&#xD;
             &gt;Fujiwara grade II [15] or &gt;Pfirrmann grade IV [14]&#xD;
&#xD;
          -  Signs of instability in any lumbar spine segment other than that undergoing fusion&#xD;
&#xD;
          -  General contraindication for elective lumbar spine surgery&#xD;
&#xD;
          -  Pathologic fracture&#xD;
&#xD;
          -  Osteoporosis with pathologic fracture&#xD;
&#xD;
          -  Active systemic infection&#xD;
&#xD;
          -  Rheumatic disease&#xD;
&#xD;
          -  Disease of bone metabolism (e.g. Paget's Disease)&#xD;
&#xD;
          -  Bone metastasis&#xD;
&#xD;
          -  Local infection focus lumbar spine&#xD;
&#xD;
          -  Seizure disorder&#xD;
&#xD;
          -  Chronic ischemia Fontaine classification IIb-IV&#xD;
&#xD;
          -  Severe heart insufficiency (NYHA III-IV)&#xD;
&#xD;
          -  Blood coagulation disorder or blood thinning therapy&#xD;
&#xD;
          -  Cortisone intake more than one month in the last 12 months before randomization&#xD;
&#xD;
          -  Simultaneous participation in another clinical trial in the 30 days before&#xD;
             randomization&#xD;
&#xD;
          -  Known allergy or intolerance to the implants&#xD;
&#xD;
          -  Dependency on investigator&#xD;
&#xD;
          -  Lack of familiarity with the German language&#xD;
&#xD;
          -  Placement in an institution by governmental or juridical advice&#xD;
&#xD;
          -  Absent legal capacity&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan Siewe, Dr.med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Cologne</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jan Siewe, Dr.med.</last_name>
    <phone>+49(0)221-478-87294</phone>
    <email>jan.siewe@uk-koeln.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Margarete Wicharz</last_name>
    <phone>+49(0)221-478-87294</phone>
    <email>margarete.wicharz@uk-koeln.de</email>
  </overall_contact_backup>
  <verification_date>September 2015</verification_date>
  <study_first_submitted>September 15, 2015</study_first_submitted>
  <study_first_submitted_qc>September 15, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2015</study_first_posted>
  <last_update_submitted>September 15, 2015</last_update_submitted>
  <last_update_submitted_qc>September 15, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 16, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Cologne</investigator_affiliation>
    <investigator_full_name>Dr. Jan Siewe</investigator_full_name>
    <investigator_title>Dr.med.</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

